Co-Authors
This is a "connection" page, showing publications co-authored by Saeid Ghavami and Seyed Nabavi.
Connection Strength
0.896
-
Rationale for Effective Prophylaxis Against COVID-19 Through Simultaneous Blockade of Both Endosomal and Non-Endosomal SARS-CoV-2 Entry into Host Cell. Clin Transl Sci. 2021 03; 14(2):431-433.
Score: 0.231
-
Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger! J Cell Mol Med. 2020 09; 24(17):10267-10269.
Score: 0.223
-
Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management? Eur J Pharmacol. 2020 Sep 05; 882:173288.
Score: 0.222
-
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2. Pharmacol Res. 2020 07; 157:104853.
Score: 0.220